Foghorn Therapeutics

Price & Volume

Stats

Open	$7.65
Previous Close	$7.72
Day Range	$7.59-$8.14
52W Range	$2.70-$10.25
Market Cap	$436.9M
Shares Short	1M

Financials

Revenue (12 Mos)	$25.5M
Revenue Growth (YoY)	-55.3%
Gross Profit (12 Mos)	-$86.3M
Diluted EPS	-$1.85

News

Yahoo Finance • last year

Foghorn Therapeutics Provides Third Quarter 2023 Financial and Corporate Update

Yahoo Finance • last year

Foghorn Therapeutics to Present at Upcoming Conferences Including New Preclinical Data from EP300 and CBP Selective Degrader Programs

Yahoo Finance • last year

Foghorn Therapeutics Announces Clinical Data From Phase 1 Study of FHD-286 in Metastatic Uveal Melanoma to Be Presented at ESMO Congress

Yahoo Finance • last year

Foghorn Therapeutics to Present Clinical and Pre-Clinical Data from Multiple Programs Across Its Diverse Pipeline at AACR-NCI-EORTC International Conference

About

CEO	Mr. Adrian H. B. Gottschalk
Address	500 Technology Square, Cambridge, MA, United States, 02139
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	116